agilon health, inc. (AGL) Stock Price

AGLStock

$85.12+252.90%52W

Market Cap$1.43B

P/E—

PEG Ratio—

Div yield—

Beta3.11

AGL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)265.40%

Price vs S&P 500 (4W)-1.98%

VGM Score67.76

Book Value / Share (Quarterly)$13.56

P/TBV (Annual)4.68x

Revenue Growth (3Y)29.87%

Cash Flow / Share (Quarterly)$-6.31

Price vs S&P 500 (YTD)382.38%

Gross Margin (TTM)3.77%

Net Profit Margin (TTM)-3.92%

EPS (TTM)$-14.06

10-Day Avg Trading Volume0.18M

EPS Excl Extra (TTM)$-14.06

Revenue Growth (5Y)37.25%

EPS (Annual)$-23.63

ROI (Annual)-241.99%

Gross Margin (Annual)-0.76%

Net Profit Margin (5Y Avg)-8.62%

Cash / Share (Quarterly)$11.06

Revenue Growth QoQ (YoY)7.15%

ROA (Last FY)-30.78%

Revenue Growth TTM (YoY)0.32%

EBITD / Share (TTM)$-16.78

ROE (5Y Avg)-90.24%

Operating Margin (TTM)-5.23%

Cash Flow / Share (Annual)$-8.97

P/B Ratio6.28x

P/B Ratio (Quarterly)7.86x

Net Income / Employee (Annual)$-457,200

EV / Revenue (TTM)0.23x

Net Interest Coverage (TTM)-46.68x

ROA (TTM)-15.58%

EPS Growth QoQ (YoY)9919.80%

EPS Incl Extra (Annual)$-23.63

Current Ratio (Annual)1.02x

Quick Ratio (Quarterly)1.00x

3-Month Avg Trading Volume0.29M

52-Week Price Return252.90%

Revenue / Employee (TTM)$6,915,900

Tangible BV / Share (Quarterly)$9.97

P/S Ratio (Annual)0.24x

Asset Turnover (Annual)4.67x

52-Week High$133.04

Operating Margin (5Y Avg)-8.83%

EPS Excl Extra (Annual)$-23.63

CapEx CAGR (5Y)78.94%

26-Week Price Return275.31%

Quick Ratio (Annual)0.89x

13-Week Price Return-34.44%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)1.08x

Enterprise Value$1.35B

Revenue / Share Growth (5Y)157.37%

Asset Turnover (TTM)3.97x

Revenue / Employee (Annual)$6,930,600

Pretax Margin (Annual)-6.81%

Cash / Share (Annual)$17.19

3-Month Return Std Dev82.03%

Gross Margin (5Y Avg)6.30%

Net Income / Employee (TTM)$-271,300

ROE (Last FY)-308.79%

Net Interest Coverage (Annual)-2.87x

EPS Basic Excl Extra (Annual)$-23.63

Receivables Turnover (TTM)5.62x

Total Debt / Equity (Quarterly)0.13x

EPS Incl Extra (TTM)$-14.06

Receivables Turnover (Annual)7.02x

ROI (TTM)-95.56%

P/S Ratio (TTM)0.24x

Pretax Margin (5Y Avg)-8.28%

Revenue / Share (Annual)$358.27

Tangible BV / Share (Annual)$3.68

Price vs S&P 500 (52W)237.37%

Year-to-Date Return394.31%

5-Day Price Return-0.43%

EPS Normalized (Annual)$-23.63

ROA (5Y Avg)-18.55%

Net Profit Margin (Annual)-6.60%

Month-to-Date Return6.95%

Cash Flow / Share (TTM)$-0.17

EBITD / Share (Annual)$-26.25

Operating Margin (Annual)-7.81%

LT Debt / Equity (Annual)0.12x

ROI (5Y Avg)-75.28%

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$-14.06

P/TBV (Quarterly)10.68x

P/B Ratio (Annual)2.25x

Pretax Margin (TTM)-4.23%

Book Value / Share (Annual)$7.64

Price vs S&P 500 (13W)-37.13%

Beta3.11x

Revenue / Share (TTM)$343.93

ROE (TTM)-110.35%

52-Week Low$7.48

vGradeB

gGradeB

mGradeB

vgmGradeB

AGL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.27	$2.15	+691.47%(+$1.88)
Q1 2026	May 6, 2026	$0.93	$2.32	+150.00%(+$1.39)
Q4 2025	Feb 25, 2026	-$6.85	-$8.95	-30.66%(-$2.10)
Q3 2025	Nov 4, 2025	-$3.36	-$6.40	-90.69%(-$3.05)
Q2 2025	Aug 4, 2025	-$2.66	-$6.30	-137.01%(-$3.64)

AGL Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.29

2.75

3.40

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
AGLagilon health, inc.	B	B	B	—	0.3%	-5.2%	-110.3%	$85.12
DVADaVita Inc.	B	C	B	16.0x	6.5%	15.1%	181.2%	$187.31
FMSFresenius Medical Care AG	A	D	C	10.7x	-0.5%	9.4%	7.2%	$22.17
SHCSotera Health Company Common Stock	D	B	C	65.5x	8.2%	32.6%	26.8%	$17.89
PGNYProgyny, Inc. Common Stock	C	B	C	35.2x	5.5%	8.6%	16.0%	$26.86
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	371.6x	—	15.4%	—	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	24.2x	25.2%	7.5%	10.3%	$9.48
PARKPark Dental Partners, Inc. Common Stock	B	F	C	17.9x	—	-2.8%	-18.3%	$18.95
CCELCryo-Cell International Inc.	C	D	B	69.5x	-2.0%	0.6%	38.2%	$4.42
MGRXMangoceuticals, Inc. Common Stock	D	F	F	—	-38.9%	-4761.2%	-106.1%	$0.29
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	—	D	F	—	-8.5%	-3975.0%	-423.8%	$1.54
NIVFNewGenIvf Group Limited Class A ordinary shares	A	C	F	0.3x	—	390.2%	45.4%	$0.28
NIVFWNewGenIvf Group Limited Warrants	—	—	D	—	—	—	—	$0.01
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	—	—	—	—	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	—	9.5%	-1.2%	-10.5%	$0.00

About agilon health, inc.

Agilon Health partners with primary care physicians to deliver value-based care to Medicare beneficiaries through a capitated, outcome-focused model. The company's platform enables physician groups to optimize healthcare delivery and reduce costs while maintaining long-term relationships with community-based practices. This model aligns financial incentives between Agilon, physicians, and payors to improve patient outcomes in the senior care market.